Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Roivant Sciences Ltd. is one of them. Roivant Sciences Ltd. (NASDAQ:ROIV) is a clinical-stage biopharmaceutical company focused on accelerating the development of medicines and technologies through its network of subsidiaries, or “Vants.” The company specializes in in-licensing promising drug candidates from larger pharmaceutical firms and advancing them toward commercialization. Its current pipeline includes moslic ...